{"url_path":"/sec/snwv/8-k/2026-06-16/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1417663/0001628280-26-043419-index.html","accession_number":"0001628280-26-043419","cik":"0001417663","ticker":"SNWV","issuer_name":"SANUWAVE Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1417663/0001628280-26-043419-index.html","primary_entity_key":"0001417663","primary_entity_name":"SANUWAVE Health, Inc."},"word_count":140,"has_tables":true,"body_markdown":"Item 7.01              Regulation FD Disclosure.\n\nOn June 16, 2026, Sanuwave Health, Inc., a Nevada corporation (the “Company”), issued a press release announcing updated guidance for the quarter ended June 30, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.\n\nThe information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}